Marshall Wace has increased its short position in the medical technology company Elekta to 0.50 percent of the capital and is thereby a new publicly disclosed short seller in the company.
Marshall Wace is a London-based hedge fund manager with global investment strategies.
There are 13 publicly disclosed short sellers in the company. In total, 15.76 percent of the capital in Elekta is shorted.
The Swedish Financial Supervisory Authority requires positions exceeding 0.1 percent to be reported, and short positions exceeding 0.5 percent to be made public.